Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 10
2021 10
2022 12
2023 17
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Peripheral nervous system manifestations of MOG antibody associated disease.
Gupta P, Paul P, Redenbaugh V, Guo Y, Lucchinetti C, Abdulrahman Y, Datta A, Shah S, Klein CJ, Pittock SJ, Flanagan EP, Dubey D. Gupta P, et al. Ann Clin Transl Neurol. 2024 Apr;11(4):1046-1052. doi: 10.1002/acn3.52001. Epub 2024 Jan 17. Ann Clin Transl Neurol. 2024. PMID: 38234084 Free PMC article.
Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: Pathological and clinical aspects.
Samadzadeh S, Olesen MN, Wirenfeldt M, Möller S, Misu T, Soelberg K, Frederiksen JL, Heegaard S, Mariotto S, Fujihara K, Ruprecht K, Andersen TL, Marignier R, Lillevang ST, Flanagan EP, Pittock SJ, Kim HJ, Bennett JL, Paul F, Sorensen GL, Weinshenker BG, Lassmann H, Asgari N. Samadzadeh S, et al. Mult Scler. 2023 Dec;29(14):1721-1735. doi: 10.1177/13524585231200720. Epub 2023 Oct 13. Mult Scler. 2023. PMID: 37830484 Free PMC article.
Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease.
Lotan I, Chen JJ, Hacohen Y, Abdel-Mannan O, Mariotto S, Huda S, Gibbons E, Wilf-Yarkoni A, Hellmann MA, Stiebel-Kalish H, Pittock SJ, Flanagan EP, Molazadeh N, Anderson M, Salky R, Romanow G, Schindler P, Duchow AS, Paul F, Levy M. Lotan I, et al. Mult Scler. 2023 Aug;29(9):1080-1089. doi: 10.1177/13524585231184738. Epub 2023 Jul 10. Mult Scler. 2023. PMID: 37431144
Cerebral enhancement in MOG antibody-associated disease.
Elsbernd P, Cacciaguerra L, Krecke KN, Chen JJ, Gritsch D, Lopez-Chiriboga AS, Sechi E, Redenbaugh V, Morris PP, Carter JL, Wingerchuk DM, Tillema JM, Valencia-Sanchez C, Thakolwiboon S, Pittock SJ, Flanagan EP. Elsbernd P, et al. J Neurol Neurosurg Psychiatry. 2023 Dec 14;95(1):14-18. doi: 10.1136/jnnp-2023-331137. J Neurol Neurosurg Psychiatry. 2023. PMID: 37221051 Free PMC article.
Comparison of MRI T2-lesion evolution in pediatric MOGAD, NMOSD, and MS.
Redenbaugh V, Chia NH, Cacciaguerra L, McCombe JA, Tillema JM, Chen JJ, Lopez Chiriboga AS, Sechi E, Hacohen Y, Pittock SJ, Flanagan EP. Redenbaugh V, et al. Mult Scler. 2023 Jun;29(7):799-808. doi: 10.1177/13524585231166834. Epub 2023 May 23. Mult Scler. 2023. PMID: 37218499
44 results